Fatigue is thought to result from reduced caloric intake, gastrointestinal side effects, metabolic adaptation, and possible central nervous system effects
Diabetic participants who took liraglutide or semaglutide often lost 15% or more of their body weight, a result not seen with other treatments or lifestyle changes alone
GLOW is a skincare stack and does not supply an injury-level TB-4 dose
Labs: Clinicians may consider running a panel that includes blood sugar markers, lipids, and liver/kidney basics (as appropriate)
The monitoring protocol is well-established because the drug has been in clinical use for years
Both medications, similar to all other GLP-1 weight loss drugs, share similar common side effects, including: Nausea Diarrhea Vomiting Constipation Some early data indicate that retatrutide may have slightly higher rates of certain side effects compared with semaglutide at higher doses because it mimics 3 different hormones and is more potent